Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Post Doctoral Fellow, University Of Pennsylvania
1981
Residency, Peter Bent Brigham Hospital, Boston, Massachusetts
1978
Doctor of Medicine, Harvard University
1976
Bachelor of Arts, Harvard University
1970
Fingerprint
Dive into the research topics where Roger Fleischman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
Projects & Grants
- 19 Finished
-
13-NHL-21-JJ:(PCI-32765FLR3001) Ibrutinib combined with either BR or R-CHOP for relapsed iNHL
Janssen Research and Development LLC
5/19/14 → 5/31/16
Project: Research project
-
14-HEM-05-SA (TED12414) Extension study for patients benefiting from treatment on ARD12130
1/1/14 → 10/31/14
Project: Research project
-
12-NHL-18-JJ (PCI-32765MCL3002) Bendamustine-Rituximab +/- Ibrutinib for newly diagnosed Mantle Cell Lymphoma (SHINE)
Fleischman, R. & Hayslip, J.
Janssen Research and Development LLC
5/10/13 → 7/31/24
Project: Research project
-
12NHL14JJ BTK Inhibitor+Ibrutinib in Patients with Mantle Cell Lymphoma who Progress After Bortezomib
Fleischman, R. & Hayslip, J.
Janssen Research and Development LLC
8/1/12 → 3/30/16
Project: Research project
-
A Phase 3 Open-Label Randomized Study to Compare the Efficacy And Safety of Rituximab Plus lenalidomide (CC-5013) versus Rituximab Plus Chemotherapy in Subjects with Previously Untreated Follicular Lymphoma
Fleischman, R., Monohan, G., Hayslip, J. & Shakil, S.
4/12/12 → 8/21/23
Project: Research project
-
Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia
Rivas, J. R., Liu, Y., Alhakeem, S. S., Eckenrode, J. M., Marti, F., Collard, J. P., Zhang, Y., Shaaban, K. A., Muthusamy, N., Hildebrandt, G. C., Fleischman, R. A., Chen, L., Thorson, J. S., Leggas, M. & Bondada, S., Nov 2021, In: Leukemia. 35, 11, p. 3188-3200 13 p.Research output: Contribution to journal › Article › peer-review
Open Access40 Scopus citations -
Essential Thrombocythemia
Fleischman, R. A., Mar 19 2020, In: New England Journal of Medicine. 382, 12, p. E21Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Chronic lymphocytic leukemia-derived IL-10 suppresses antitumor immunity
Alhakeem, S. S., McKenna, M. K., Oben, K. Z., Noothi, S. K., Rivas, J. R., Hildebrandt, G. C., Fleischman, R. A., Rangnekar, V. M., Muthusamy, N. & Bondada, S., Jun 15 2018, In: Journal of Immunology. 200, 12, p. 4180-4189 10 p.Research output: Contribution to journal › Article › peer-review
Open Access45 Scopus citations -
Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia
McKenna, M. K., Noothi, S. K., Alhakeem, S. S., Oben, K. Z., Greene, J. T., Mani, R., Perry, K. L., Collard, J. P., Rivas, J. R., Hildebrandt, G. C., Fleischman, R. A., Durbin, E. B., Byrd, J. C., Wang, C., Muthusamy, N., Rangnekar, V. M. & Bondada, S., Jun 28 2018, In: Blood. 131, 26, p. 2943-2954 12 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Refractory macrocytic anemias in patients with clonal hematopoietic disorders and isolated mutations of the spliceosome gene ZRSR2
Fleischman, R. A., Stockton, S. S. & Cogle, C. R., Oct 2017, In: Leukemia Research. 61, p. 104-107 4 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations